Exova Group, noting recent market speculation, confirmed on Monday it received proposals from Element Materials Technology, Jacobs Holding and PAI Partners SAS regarding a possible cash offer for the company.
Testing and advisory services company Exova Group has booked a profit of £20.1m for the first half, from £18.3m a year ago, and raised its interim dividend up to 1.05p a share, from 1p.
AstraZeneca, the UK's second-biggest drug developer, will this week outline its next big hope in the battle against cancer by unveiling new data on a class of treatments, known as DNA damage response (DDR) medicines, at a conference in Chicago. The drugs work by stopping cancerous cells repairing themselves, in effect by blocking them from attracting the proteins needed to regenerate, as well as proving much less damaging to the body than chemotherapy.
Exova Group: Goldman Sachs reiterates buy with a 195p target.
Exova expects modest full-year organic growth at constant currency rates and earnings in line with previous guidance, adjusted for the just-announced sale of its Food, Water and Pharmaceutical (FWP) business in the UK and Ireland.
City sources predict the FTSE 100 will open 52 points lower than Tuesday's close of 6,664.54.
A round-up of the biggest director deals today so far.
Housebuilders were among the worst performing stocks on the FTSE 250 on Tuesday afternoon as rate-hike speculation continued to dominate sentiment. Data released earlier in the session showed that UK construction activity reached a seven-month high in August.
UK stock rose for the third straight session on Tuesday after data showed that growth in the British construction sector unexpectedly accelerated last month.
UK stocks were closing in a two-month high on Tuesday morning, rising for the third straight day, as investors took an optimistic approach ahead of the return of US markets after a long weekend.
Shares in Perform Group surged on Monday after the company, which commercialises multimedia sports content across digital platforms, confirmed it had received a takeover bid from investment group Access Industries.
Technological company Exova reported a wider first-half loss as revenue fell on headwinds in aerospace and transportation sectors.
1630: Close The biggest London-listed stocks ended the week on an upbeat note after data-heavy session around for the UK, the Eurozone and the US. Data out in the UK showed that while British consumer confidence rose this month, rises are starting to flatten out and people are uncertain about their prospects. In other news, house prices inched just 0.1% higher in August, according to a monthly national housing survey. Eurozone consumer prices slowed to a 0.3% year-on-year rate of change in August, while US household purchases dropped 0.1% following a 0.4% increase in June. Analysts had predicted a 0.2% rise. The FTSE 100 closed 13.95 points at 6,819.75.
Gaming giant Bwin.party was a strong riser despite reporting wider first-half losses, which reflected a fall in casino and poker revenues. Loss before tax in the six months to 30 June 2014 came to €94m, up from €11.6 the previous year.
UK stocks were registering only a slight advance towards midday, as investors debated the prospect for further easing from the European Central Bank at the 4 September policy meeting and ahead of a spate of high-frequency data due for release later Stateside.
UK stocks were registering only slight gains in the early going ahead of the release of the latest Eurozone inflation numbers and a spate of high-frequency data which are due for release later on Stateside.
ASOS: Goldman Sachs reduces target price from 7300p to 6250p, while upgrading to buy.